Liefke, Jonas
Sepúlveda-Martinez, Alvaro
Shakya, Snehlata
Ehrenborg, Katarina Steding
Arheden, Håkan
Morsing, Eva
Ley, David
Heiberg, Einar
Hedström, Erik http://orcid.org/0000-0003-0041-9357
Funding for this research was provided by:
The Swedish Heart-Lung Foundation (20200808, 20180510, 20200179, 20210606, and 20220575)
Swedish Research Council grant (2020-01236)
the Swedish governmental funding of clinical research
Region Skåne
Skåne University Hospital
Lund University
Article History
Received: 24 April 2023
Accepted: 4 August 2023
First Online: 19 August 2023
Declarations
:
: Dr. Einar Heiberg is the CTO and founder of Medviso AB, Lund, which provides the software Segment used in the current paper. Segment is freely available for research but is also available for commercial use. The remaining authors declare that they have no competing interests.
: The regional Ethics Review Board approved the study (Dnr 2013/244) and all participants and their guardians when appropriate provided written informed content before participation.